Galenica OTC Goes From Strength To Strength At Home And Abroad

Galenica outpaced the growth of the OTC market at home, while recording a double-digit gain abroad, to drive up its consumer health product sales in 2024.

(Shutterstock)

More from Earnings

More from Strategy